XML 51 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule Of Assumptions In Determining The Fair Value Of Shares Issued Under The Employee Stock Purchase Plan
In determining the fair value of the right to purchase under the Employee Stock Purchase Plan, the Company uses the Black-Scholes option pricing model that employs the following key assumptions:
 Employee Stock Purchase Plan
Years Ended September 30,
 202220212020
Risk-free interest rate
0.05% - 0.62%
0.07% - 0.13%
1.10% - 1.97%
Expected dividend— — — 
Expected term0.5 years0.5 years0.5 years
Expected volatility
26.34% - 31.57%
29.67% - 37.22%
26.32% - 41.94%
Schedule Of Summary Of Restricted Stock Unit Activity
A summary of restricted stock unit activity under the Plan is as follows:
Performance Stock UnitsRestricted Stock Units
Outstanding
Performance
Stock Units
Weighted
Average
Grant Date
Fair Value
Outstanding
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
Balance, September 30, 2021230,926 $136.47 1,340,548 $141.90 
Units granted111,283 200.74 1,118,854 206.45 
Units vested(119,889)215.12 (1,122,583)188.04 
Units cancelled(14,204)151.07 (199,200)170.35 
Balance, September 30, 2022208,116 $169.99 1,137,619 $184.59 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions In determining the fair value of the portion of the performance awards based on Total Shareholder Return, the Company uses a Monte Carlo simulation model that employs the following key assumptions:
Expected Volatility
Fair ValueExpected TermRisk-FreeIndexExpected
Grant Dateper Share(in years)Interest RateF5MembersDividend
November 1, 2021
Tranche 1$283.35 0.910.13 %26.21 %27.27 %— 
Tranche 2$302.53 1.910.47 %35.13 %42.87 %— 
Tranche 3$308.76 2.910.76 %32.54 %38.24 %— 
Schedule of Nonvested Restricted Stock Units Activity
As of September 30, 2022, the following annual equity grants for executive officers or a portion thereof are outstanding:
Grant DateRSUs GrantedVesting ScheduleVesting PeriodDate Fully Vested
November 1, 2021160,384
Quarterly, Annually1,2
3 yearsNovember 1, 2024
November 2, 2020257,568
Quarterly, Annually1
3 yearsNovember 1, 2023
November 1, 2019228,616
Quarterly, Annually1
3 yearsNovember 1, 2022
November 1, 2018144,066
Quarterly, Annually1
3 yearsNovember 1, 2021
(1)50% of the annual equity grant vests in equal quarterly increments and 50% is subject to the Company achieving specified annual performance goals.
(2)For the Company's Chief Executive Officer, 40% of the annual equity grant vests in equal quarterly increments and 60% is subject to the Company achieving specified annual performance goals.
Schedule Of Stock Option Activity
A summary of stock option activity under all of the Company’s plans is as follows:
 Options Outstanding
 Number of
Shares
Weighted
Average
Exercise Price
per Share
Balance, September 30, 2021324,624 $30.83 
Options granted— — 
Options exercised(143,128)25.24 
Options cancelled(16,700)53.98 
Balance, September 30, 2022164,796 $33.34 
Schedule Of Outstanding Stock Options Currently Exercisable, Vested And Expected To Vest
A summary of options outstanding that are exercisable and that have vested and are expected to vest as of September 30, 2022 is as follows:
Number of
Shares
Weighted
Average
Remaining
Contractual
Life (in Years)
Weighted
Average
Exercise
Price
per Share
Aggregate
Intrinsic
Value(1)
 (In thousands)
Stock options outstanding164,796 6.45$33.34 $18,357 
Exercisable127,072 6.20$30.76 $14,482 
Vested and expected to vest162,713 6.42$33.20 $18,147 
(1)Aggregate intrinsic value represents the difference between the fair value of the Company’s common stock underlying these options at September 30, 2022 and the related exercise prices.
Schedule Of Equity Based Awards (Including Stock Options And Restricted Stock Units)
As of September 30, 2022, equity based awards (including stock options and restricted stock units) are available for future issuance as follows:
 Awards
Available for
Grant
Balance, September 30, 20211,988,410 
Granted(1,255,975)
Cancelled327,201 
Additional shares reserved (terminated), net1,013,142 
Balance, September 30, 20222,072,778